Nasdaq Considers Delisting Subgen AI Over Alleged Disclosure Breaches
Nasdaq is considering delisting Subgen AI over alleged disclosure breaches.
Related stories
FDA Approves AstraZeneca’s Imfinzi Combination
The FDA approved AstraZeneca’s Imfinzi combination with enfortumab.
M impact | REGULATION | Nov 13, 2026, 07:18 PM UTC
SEC Proposes Executive and Director Compensation Disclosure Reforms
Washington D.C., Nov. 13, 2026 The Securities and Exchange Commission today proposed rule amendments to make its executive and director compensation disclosure requirements more pr
H impact | REGULATION | Nov 13, 2026, 06:54 PM UTC
Supreme Court to Weigh Trump Asylum Restrictions
The Supreme Court will consider Trump administration restrictions on asylum at the US-Mexico border, according to the administration.
L impact | REGULATION | Nov 13, 2026, 06:49 PM UTC
Supreme Court to Hear Robinhood Bid to Avoid IPO Lawsuit
M impact | REGULATION | Nov 13, 2026, 06:45 PM UTC
FTC Sues to Block Proposed $3.5 Billion Covetrus-MWI Merger
The FTC sued to block Covetrus from acquiring rival MWI Veterinary Supply. Covetrus agreed in February to acquire Cencora’s MWI animal-health business in a deal worth $3.5 billion.
M impact | REGULATION | Nov 13, 2026, 06:23 PM UTC
Nasdaq Stockholm Considers Delisting Referral for Subgen AI
Nasdaq Stockholm is considering referring Subgen AI AB to its Disciplinary Committee with a motion to delist its shares, alleging disclosure-rule and EU market-abuse regulation bre
L impact | REGULATION | Nov 13, 2026, 06:20 PM UTC